Raquel Pinto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Raquel Pinto has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Andreia Silva
Nephrology Department, Centro Hospitalar Tondela Viseu, Viseu, Portugal
2 shared publications - Carla Lima
Nephrology Department, Centro Hospitalar Tondela Viseu, Viseu, Portugal
2 shared publications - Luisa Lemos Costa
Nephrology Department, Centro Hospitalar Tondela Viseu, Viseu, Portugal
2 shared publications - Sérgio Lemos
Nephrology Department, Centro Hospitalar Tondela Viseu, Viseu, Portugal
2 shared publications - Ana Cunha Rodrigues
Centro Hospitalar Tondela Viseu, Portugal
1 shared publication - André Ferreira
Division of Nephrology, Department of Medicine, Instituto Português de Oncologia do Porto, FG, E.P.E., Porto, Portugal
1 shared publication
Latest Publications
- Open Access
- 12 February 2022
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Case report: rivaroxaban related nephropathy
The characteristics of direct oral anticoagulants (DOACs) make them more appealing for prevention of thromboembolic events than vitamin K antagonists (VKA). Despite that, both classes have been a recognized as a cause of anticoagulant related nephropathy (ARN). Herein we describe a case of a 72-year-old man, with chronic kidney disease (CKD), medicated with rivaroxaban, who presented with acute kidney injury (AKI) and microscopic hematuria. The kidney biopsy revealed anticoagulant related-nephropathy. Rivaroxaban was suspended, the patient showed improvement of renal function and apixaban was prescribed. This case emphasizes the need for careful monitoring of serum creatinine when these drugs are prescribed, especially in high risk groups.
- 12 February 2022
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Open AccessCase report: rivaroxaban related nephropathy
The characteristics of direct oral anticoagulants (DOACs) make them more appealing for prevention of thromboembolic events than vitamin K antagonists (VKA). Despite that, both classes have been a recognized as a cause of anticoagulant related nephropathy (ARN). Herein we describe a case of a 72-year-old man, with chronic kidney disease (CKD), medicated with rivaroxaban, who presented with acute kidney injury (AKI) and microscopic hematuria. The kidney biopsy revealed anticoagulant related-nephropathy. Rivaroxaban was suspended, the patient showed improvement of renal function and apixaban was prescribed. This case emphasizes the need for careful monitoring of serum creatinine when these drugs are prescribed, especially in high risk groups.